Endo International PLC (ENDP)

pos +0.00
Today's Range: 0.00 - 0.00 | ENDP Avg Daily Volume: 9,203,500
Last Update: 05/22/17 - 4:00 PM EDT
Volume: 0
YTD Performance: -28.11%
Open: $0.00
Previous Close: $11.84
52 Week Range: $9.70 - $24.93
Oustanding Shares: 223,112,543
Market Cap: 2,650,577,011
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 7
Moderate Buy 0 0 1 1
Hold 9 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.29 2.25 2.24 2.12
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -0.80
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-0.80 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-8.15% -23.32% -83.85%
Revenue 22.70 0.50 0.15
Net Income 0.00 5.00 0.00
EPS 0.00 1.50 0.00
Earnings for ENDP:
Revenue 4.01B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.73 $0.80 $3.62 $3.59
Number of Analysts 8 8 10 10
High Estimate $0.81 $0.85 $3.75 $4.24
Low Estimate $0.65 $0.73 $3.51 $2.88
Prior Year $0.86 $1.01 $4.73 $3.62
Growth Rate (Year over Year) -14.83% -20.79% -23.47% -0.97%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

3 Small Biotech Value Plays Real Money Pro($)

These stocks will be great stories in the second half of 2017, and are significantly undervalued.
Finding bullish and bearish reversals in the market.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Not much action in the markets since our last update with the major indices continuing to grind slightly higher as we try to close out a solid…
Even among the losers, buys are scarce.
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.
In our last post we discussed large-cap biotech names that have been beaten up in 2016, are cheap and hopefully will see better days in 2017. Here are a few small-cap biotechs I would keep an eye on in 2017.
Which stocks have shown these patterns in the past week.
Thursday felt a lot like capitulation in this space. I was buying.
It appears Twitter will need more than takeover chatter to stay aloft, Oppenheimer analysts say.

Columnist Conversations

we have a beauty here, we'll roll it up SOLD XLNX JUN 65 CALL AT 3.6 (in at 1.60) BOUGH...
we have a nice winner, we'll roll up SOLD MOMO JUL 40 CALL AT 7.1 (in at 4.2) BOUGHT MOMO JUL 45 CALL AT...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.